Recalls / Class II
Class IID-0051-2025
Product
BEVACIZUMAB (AVASTIN)1.25mg/0.05mL, Sterile Injection, 0.5 mL Single-Dose Syringe, Rx Only, Repackaged by: Medivant Healthcare: 24416 N 19th Ave, Phoenix, AZ, NDC 81483-0041-1
- Affected lot / code info
- Lot #: D24005, Exp. Date 20 February 2025; D24006, Exp. Date 21 February 2025; D24007, Exp. Date 22 February 2025; D24008, Exp. Date 19 March 2025; D24009, Exp. Date 20 March 2025; D24012, Exp. Date 25 April 2025.
Why it was recalled
Lack of Sterility Assurance
Recalling firm
- Firm
- Tailstorm Health INC
- Notification channel
- Letter
- Type
- Voluntary: Firm initiated
- Address
- 24416 N 19th Ave Ste 200, N/A, Phoenix, Arizona 85085-1400
Distribution
- Quantity
- 27,560 Syringes
- Distribution pattern
- Nationwide Within U.S.
Timeline
- Recall initiated
- 2024-11-06
- FDA classified
- 2024-11-18
- Posted by FDA
- 2024-11-27
- Terminated
- 2025-03-28
- Status
- Terminated
Source: openFDA Drug Enforcement endpoint. Recall record D-0051-2025. The FDA issues recall classifications as health-hazard assessments, not legal findings; for legal claims consult a licensed attorney.